NYSE:MMM - 3M Stock Price, Price Target & More

3M trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMM."

3M announced a quarterly dividend on Tuesday, May 8th. Investors of record on Friday, May 18th will be given a dividend of $1.36 per share on Tuesday, June 12th. This represents a $5.44 dividend on an annualized basis and a dividend yield of 2.72%. The ex-dividend date is Thursday, May 17th. View 3M's Dividend History.

3M Co (NYSE:MMM) announced its earnings results on Tuesday, April, 24th. The conglomerate reported $2.50 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $2.50. The conglomerate had revenue of $8.28 billion for the quarter, compared to analysts' expectations of $8.21 billion. 3M had a return on equity of 50.11% and a net margin of 12.83%. 3M's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter last year, the firm posted $2.16 earnings per share. View 3M's Earnings History.

3M is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for 3M.

3M issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided earnings per share (EPS) guidance of $10.20-10.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.54.

16 brokers have issued 12-month target prices for 3M's shares. Their forecasts range from $200.00 to $285.00. On average, they anticipate 3M's stock price to reach $229.6667 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price. View Analyst Ratings for 3M.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 3M in the last year. There are currently 4 sell ratings, 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to 3M include Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), Baxter International (BAX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

Press coverage about MMM stock has trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. 3M earned a daily sentiment score of 0.13 on Accern's scale. They also gave news stories about the conglomerate an impact score of 45.84 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

3M's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Jensen Investment Management Inc. (0.25%), Confluence Investment Management LLC (0.09%), Swedbank (0.09%), Alecta Pensionsforsakring Omsesidigt (0.08%), Retirement Systems of Alabama (0.07%) and Gateway Investment Advisers LLC (0.06%). Company insiders that own 3M stock include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Julie L Bushman, Khandpur K Ashish, Kimberly F Price, Marlene Mary Mcgrath, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Institutional Ownership Trends for 3M.

MMM stock was sold by a variety of institutional investors in the last quarter, including Sabal Trust CO, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Hartford Investment Management Co., GWM Advisors LLC, Capital One National Association, NN Investment Partners Holdings N.V., Radnor Capital Management LLC and Manning & Napier Group LLC. Company insiders that have sold 3M company stock in the last year include Eric D Hammes, Frank R Jr Little, Hak Cheol Shin, Inge G Thulin, Ippocratis Vrohidis, Ivan K Fong, James L Bauman, Jon T Lindekugel, Khandpur K Ashish, Michael F Roman, Nicholas C Gangestad and Paul A Keel. View Insider Buying and Selling for 3M.

MMM stock was acquired by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Oakbrook Investments LLC, Jensen Investment Management Inc., Confluence Investment Management LLC, Assenagon Asset Management S.A., State of Alaska Department of Revenue, Gofen & Glossberg LLC IL and Calamos Advisors LLC. View Insider Buying and Selling for 3M.

Shares of MMM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMM stock can currently be purchased for approximately $199.78.

3M has a market capitalization of $119.97 billion and generates $31.66 billion in revenue each year. The conglomerate earns $4.86 billion in net income (profit) each year or $9.17 on an earnings per share basis. 3M employs 91,536 workers across the globe.

3M's mailing address is 3M CENTER BLDG. 220-11W-02, ST PAUL MN, 55144. The conglomerate can be reached via phone at 651-733-1110.